Clinical feasibility of 90 Y digital PET/CT for imaging microsphere biodistribution following radioembolization

Abstract

Purpose

The purpose of this study was to evaluate the clinical feasibility of next generation solid-state digital photon counting PET/CT (dPET/CT) technology and imaging findings in patients following ⁹⁰Y microsphere radioembolization in comparison with standard of care (SOC) bremsstrahlung SPECT/CT (bSPECT/CT).

Methods

Five patients underwent SOC ⁹⁰Y bremsstrahlung imaging immediately following routine radioembolization with 3.5 ± 1.7 GBq of ⁹⁰Y-labeled glass microspheres. All patients also underwent dPET/CT imaging at 29 ± 11 h following radioembolization. Matched pairs comparison was used to compare image quality, image contrast and ⁹⁰Y biodistribution between dPET/CT and bSPECT/CT images. Volumetric assessments of ⁹⁰Y activity using different isocontour thresholds on dPET/CT and bSPECT/CT images were also compared.

Results

Digital PET/CT consistently provided better visual image quality and ⁹⁰Y-to-background image contrast while depicting ⁹⁰Y biodistribution than bSPECT/CT. Isocontour volumetric assessment using a 1% threshold precisely outlined ⁹⁰Y activity and the treatment volume on dPET/CT images, whereas a more restrictive 20% threshold on bSPECT/CT images was needed to obtain comparable treatment volumes. The use of a less restrictive 10% threshold isocontour on bSPECT/CT images grossly overestimated the treatment volume when compared with the 1% threshold on dPET/CT images.

Conclusions

Digital PET/CT is clinically feasible for the assessment of ⁹⁰Y microsphere biodistribution following radioembolization, and provides better visual image quality and image contrast than routine bSPECT/CT with comparable acquisition times. With further optimization and clinical validation, dPET technology may allow faster and more accurate imaging-based assessment of ⁹⁰Y microsphere biodistribution.

http://ift.tt/2rlw3xr